• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中国人群中,ErbB4 内的一种多态性与肝细胞癌的风险相关。

A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population.

机构信息

Department of Gastroenterology, Suzhou Municipal Hospital, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215002, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2012 Jan 28;18(4):383-7. doi: 10.3748/wjg.v18.i4.383.

DOI:10.3748/wjg.v18.i4.383
PMID:22294845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3261534/
Abstract

AIM

To investigate the association between hepatocellular carcinoma (HCC) susceptibility and a 12-bp insertion/deletion polymorphism (rs6147150) in the 3'UTR of ErbB4.

METHODS

Using a case-control design, the rs6147150 genotypes in 270 patients with HCC and 270 healthy controls were determined by direct polymerase chain reaction and polyacrylamide gel electrophoresis. Logistic regression was used to analyze the association between the polymorphism and cancer risk.

RESULTS

Computational modeling suggested that rs6147150 was located in the seed region of hsa-let-7c, a potential target sequence in ErbB4 3'UTR. Logistic regression analysis showed that, compared with individuals homozygous for wild-type, heterozygotes [adjusted odds ratio (OR) = 1.48, 95% confidence interval (CI) = 1.03-2.17, P = 0.034] and individuals homozygous for 12-bp del/del (OR = 2.50, 95% CI = 1.37-4.56, P = 0.001) were at significantly higher risk of HCC. Carriers of the "del" allele of rs6147150 had a 1.59-fold increased risk for HCC (95% CI = 1.22-2.07, P = 0.003).

CONCLUSION

rs6147150 may be associated with HCC risk, in part through let-7c-mediated regulation, and may be involved in the pathogenesis of HCC in Chinese populations.

摘要

目的

研究表皮生长因子受体 4(ErbB4)3'UTR 中的 12 个碱基插入/缺失多态性(rs6147150)与肝细胞癌(HCC)易感性的关联。

方法

采用病例对照设计,通过直接聚合酶链反应和聚丙烯酰胺凝胶电泳检测 270 例 HCC 患者和 270 例健康对照者的 rs6147150 基因型。采用 logistic 回归分析该多态性与癌症风险的关系。

结果

计算模型提示 rs6147150 位于 hsa-let-7c 的种子区,后者是 ErbB4 3'UTR 的一个潜在靶序列。logistic 回归分析显示,与野生型纯合子相比,杂合子(调整比值比(OR)=1.48,95%置信区间(CI)=1.03-2.17,P=0.034)和 12 个碱基缺失纯合子(OR=2.50,95%CI=1.37-4.56,P=0.001)患 HCC 的风险显著增加。rs6147150 的“del”等位基因携带者患 HCC 的风险增加 1.59 倍(95%CI=1.22-2.07,P=0.003)。

结论

rs6147150 可能与 HCC 风险相关,部分原因是通过 let-7c 介导的调节,并且可能参与了中国人群 HCC 的发病机制。

相似文献

1
A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population.在中国人群中,ErbB4 内的一种多态性与肝细胞癌的风险相关。
World J Gastroenterol. 2012 Jan 28;18(4):383-7. doi: 10.3748/wjg.v18.i4.383.
2
An insertion/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population.I型胶原蛋白α2(COL1A2)3'非翻译区的插入/缺失多态性与中国人群肝细胞癌的易感性相关。
Cancer Genet. 2011 May;204(5):265-9. doi: 10.1016/j.cancergen.2011.03.007.
3
Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population.在中国汉族人群中,ErbB4基因变异会增加患结直肠癌的风险。
Cancer Biomark. 2014;14(6):435-9. doi: 10.3233/CBM-140420.
4
Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.SGSM3基因3'非翻译区插入/缺失多态性与肝细胞癌风险的关联。
Tumour Biol. 2014 Jan;35(1):295-301. doi: 10.1007/s13277-013-1039-x. Epub 2013 Aug 6.
5
A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility.IFNAR1 3'UTR 内 miR-1231 结合位点多态性与肝细胞癌易感性相关。
Gene. 2012 Oct 1;507(1):95-8. doi: 10.1016/j.gene.2012.06.073. Epub 2012 Jul 20.
6
An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese.中国人β-联蛋白重复含蛋白(βTrCP)3' 非翻译区插入/缺失多态性与肝细胞癌易感性相关。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):552-6. doi: 10.1016/j.bbrc.2009.11.096. Epub 2009 Nov 24.
7
An indel polymorphism in the 3' untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population.HMGB1 3'UTR 中的插入缺失多态性通过调节中国人群中 HMGB1 的转录活性而增加肝细胞癌的风险。
Neoplasma. 2020 Jan;67(1):61-67. doi: 10.4149/neo_2019_190221N147. Epub 2019 Nov 26.
8
The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population.线粒体DNA 9碱基对缺失多态性是中国人群肝细胞癌的一个危险因素。
Genet Test Mol Biomarkers. 2012 May;16(5):330-4. doi: 10.1089/gtmb.2011.0208. Epub 2012 Jan 27.
9
A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population.一个位于 PDCD6IP 启动子区的功能性插入/缺失多态性与中国人群肝癌易感性相关。
DNA Cell Biol. 2013 Aug;32(8):451-7. doi: 10.1089/dna.2013.2061. Epub 2013 Jun 18.
10
A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population.MDM2 组成性启动子中的 40-bp 插入/缺失多态性增加中国人群罹患肝细胞癌的风险。
Gene. 2012 Apr 10;497(1):66-70. doi: 10.1016/j.gene.2012.01.004. Epub 2012 Jan 18.

引用本文的文献

1
The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.POR 基因 rs10954732 多态性降低肝细胞癌易感性,hepsin 作为基于蛋白质组学的预后生物标志物与免疫浸润相关。
J Transl Med. 2022 Feb 14;20(1):88. doi: 10.1186/s12967-022-03282-1.
2
Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.ERBB4 基因多态性与中国汉族人群非小细胞肺癌风险和预后的关联:一项基于人群的病例对照研究。
Medicine (Baltimore). 2021 May 14;100(19):e25762. doi: 10.1097/MD.0000000000025762.
3
Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection.在使用直接作用抗病毒药物治疗丙型肝炎感染时,可能影响肝脏肿瘤发生率的宿主药物遗传学因素。
Heliyon. 2021 May 3;7(5):e06908. doi: 10.1016/j.heliyon.2021.e06908. eCollection 2021 May.
4
An indel polymorphism in the 3' untranslated region of confers risk for hepatocellular carcinoma possibly by regulating transcriptional activity in a Chinese population.在一个中国人群中,(基因)3'非翻译区的一个插入缺失多态性可能通过调节转录活性而赋予肝细胞癌风险。
Oncol Lett. 2018 May;15(5):8088-8094. doi: 10.3892/ol.2018.8347. Epub 2018 Mar 26.
5
Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.ERBB4基因变异与慢性乙型肝炎病毒感染有关。
Oncotarget. 2016 Jan 26;7(4):4981-92. doi: 10.18632/oncotarget.6650.
6
SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.单核苷酸多态性对微小RNA表达的调控及后续结肠癌风险
PLoS One. 2015 Dec 2;10(12):e0143894. doi: 10.1371/journal.pone.0143894. eCollection 2015.
7
MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.微小RNA相关单核苷酸多态性与食管腺癌和巴雷特食管的风险:BEACON联盟的全基因组关联分析后研究
PLoS One. 2015 Jun 3;10(6):e0128617. doi: 10.1371/journal.pone.0128617. eCollection 2015.
8
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.微小RNA结合位点多态性作为癌症管理和研究中的生物标志物
Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014.
9
MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.微小 RNA 相关多态性与食管鳞癌遗传易感性。
Mol Genet Genomics. 2014 Dec;289(6):1123-30. doi: 10.1007/s00438-014-0873-x. Epub 2014 Jun 12.
10
Epigenetics of hepatocellular carcinoma: role of microRNA.肝细胞癌的表观遗传学:miRNA 的作用。
World J Gastroenterol. 2013 Sep 7;19(33):5439-45. doi: 10.3748/wjg.v19.i33.5439.

本文引用的文献

1
Regulation of ErbB receptor signalling in cancer cells by microRNA.微小 RNA 对癌细胞中 erbB 受体信号的调节。
Curr Opin Pharmacol. 2010 Dec;10(6):655-61. doi: 10.1016/j.coph.2010.08.011. Epub 2010 Sep 21.
2
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.全基因组关联研究鉴定出 1p36.22 是慢性乙型肝炎病毒携带者肝细胞癌的一个新易感位点。
Nat Genet. 2010 Sep;42(9):755-8. doi: 10.1038/ng.638. Epub 2010 Aug 1.
3
The role of signaling pathways in the development and treatment of hepatocellular carcinoma.信号通路在肝细胞癌发生发展及治疗中的作用。
Oncogene. 2010 Sep 9;29(36):4989-5005. doi: 10.1038/onc.2010.236. Epub 2010 Jul 19.
4
Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.单核苷酸多态性位于 microRNA 靶位点内会影响肿瘤易感性。
Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.
5
Mechanisms of resistance to HER family targeting antibodies.HER 家族靶向抗体耐药机制。
Exp Cell Res. 2010 Apr 15;316(7):1083-100. doi: 10.1016/j.yexcr.2010.01.009. Epub 2010 Jan 11.
6
Potential of ErbB4 antibodies for cancer therapy.ErbB4 抗体在癌症治疗中的潜力。
Future Oncol. 2010 Jan;6(1):37-53. doi: 10.2217/fon.09.144.
7
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.IκBα基因启动子多态性与C型乙型肝炎病毒感染患者的肝癌发生有关。
Carcinogenesis. 2009 Nov;30(11):1916-22. doi: 10.1093/carcin/bgp226. Epub 2009 Oct 1.
8
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.黑色素瘤中酪氨酸激酶组分析揭示了ERBB4中的复发性突变。
Nat Genet. 2009 Oct;41(10):1127-32. doi: 10.1038/ng.438. Epub 2009 Aug 30.
9
Analysis of ErbB receptors in pulmonary carcinoid tumors.肺类癌肿瘤中表皮生长因子受体(ErbB)的分析
Clin Cancer Res. 2009 May 15;15(10):3315-24. doi: 10.1158/1078-0432.CCR-08-2549.
10
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.原发性结直肠癌及其相应转移灶中ErbB 1-4的表达改变。
Anticancer Res. 2009 May;29(5):1489-94.